Satisfaction With XEN Gel Stent Versus Trabeculectomy for the Treatment of Glaucoma

Exclusion Criteria

• •Diagnosed with angle closure glaucoma in the study eye
• •Presence of a secondary glaucoma, pseudoexfoliation glaucoma, or pigmentary glaucoma
• •Presence of neovascular, uveitic, or angle recession glaucoma or any glaucoma associate with vascular disorders
• •Prior incisional glaucoma surgery, canal-based surgery, suprachoroidal space-based surgery (trabeculectomy, viscocanalostomy, canaloplasty, shunts of any type, collagen implants, etc.) or a cilio-ablative procedure
• •Clinically significant inflammation or infection in the study eye within 30 days prior to the baseline visit (e.g. blepharitis, conjunctivitis, keratitis, uveitis, herpes simplex infection)
• •History of corneal surgery, corneal opacities, or corneal disease
• •Prior intraocular surgery in either eye ≤ 3 months prior to study enrollment with the exception of uncomplicated cataract surgery in either eye ≥ 1 month prior to study enrollment
• •Anticipated ocular surgery in either eye within 6 months of baseline
• •Concomitant cataract surgery scheduled at the time of glaucoma procedure
• •The study eye is defined as the eye receiving surgical intervention with either XEN or trabeculectomy.